day 1 agenda
| Scientific Program | ||
| Day -1: June (29, 2026) | ||
| Meeting Hall - 1 | ||
| Registrations Open (08:30-09:10) | ||
| Opening Ceremony (09:10-09:30) | ||
| Keynote Talks | ||
| Yifan Li, Shanxi Cancer Hospital, China |
09:30-10:00 | Title: How can precision medicine strategies be integrated into postoperative management for hepatobiliary, pancreatic, and gastric cancers? |
| TBA | 10:00-10:30 | TBA |
| Natalia Neparidze, Yale University., United States |
10:30-11:00 | Title: Systematic Community Outreach Efforts to Raise Awareness of Myeloma |
| Group Photo & Refreshment Break (11:00-11:20) | ||
| Scientific Session I | ||
| Manish K Tripathi, University of Texas Rio Grande Valley, United States |
11:20-11:40 | Title: YBX1 promotes sorafenib resistance in hepatocellular carcinoma and serves as a potential therapeutic target |
| Vimolmas Tansathitaya, College of Sports Science and Technology, Mahidol University, Thailand |
11:40-12:00 | Title: The Impact of Air Pollution on Lung Cancer Deformation: A Look at Nitrogen Dioxide Exposure and Long-Term Outdoor Physical Activity |
| Zhenqiang Yao, University of Rochester Medical Center, United States |
12:00-12:20 | Title: Localized apoptosis induction as a new strategy in solid cancer treatment |
| Melinda Ildiko Mitranovici, George Emil Palade University of Medicine, Romania |
12:20-12:40 | Title: Autophagy and its Dual Role, Similitudes and Differences between Trophoblast Cells and Cancer Stem Cells, a Narrative Review |
| Jun Lu, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, China |
12:40-13:00 | Title: Remodeling the tumor immune microenvironment through MEK/RTKs co-inhibition to overcome immunotherapy resistance in KRAS-mutant NSCLC |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Scientific Session II | ||
| Thorsten Schaefer, University and University Hospital Basel, Switzerland |
14:00-14:20 | Title: New insights into the functional significance of stem cell factor and oncogene SOX2 |
| João Paulo Kawaoka Matushita Junior, AC Camargo Cancer Center, Brazil |
14:20-14:40 | Title: Percutaneous Biliopancreatic Dual-Duct Intervention in Altered Anatomy Using Digital Cholangioscopy |
| Gulcin Ertas, SBÜ Ankara Oncology Training and Researche Hospital, Turkey |
14:40-15:00 | Title: General features of metaplastic breast carcinoma and case of bilateral squamous cell MBC |
| Filippo Dell’Anno, Istituto Zooprofilattico sperimentale Piemonte, Liguria e Valle d'Aosta, Italy |
15:00-15:20 | Title: Environmental Pollution as a Driver of Cancer in Pets: Insights from Canine and Feline Epidemiology |
| Aisha Swaih, AstraZeneca, United Kingdom |
15:20-15:40 | Title: Discovery of a highly selective and blood-brain barrier penetrant irreversible TKI targeting EGFRExon20 Insertions |
| Junfang Zheng, Capital Medical University, China |
15:40-16:00 | Title: KAT8-mediated MDH2 lactylation promotes renal cancer progression by enhancing mitochondrial function and stress resistance |
| Refreshment Break(16:00-16:10) | ||
| Haihe Wang, Sun Yat-sen University, China |
16:10-16:30 | Title: Roles of a small adaptor SH3BGRL in metastasis and chemo-resistance of breast tumor cells |
| Wan-Sheng Liu, The Pennsylvania State University, United States |
16:30-16:50 | Title: Shared RAR Pathway Mechanisms of PRAME Cancer/Testis Antigens in Germ Cells and Tumors |
| Speaker Slot Available | 16:50-17:10 | Speaker Slot Available |
| Pannel Discussions | ||
| Please note that this program is tentative, and the timings are subject to change. | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
day 2 agenda
| Scientific Program | ||
| Day -2: June (30, 2026) | ||
| Meeting Hall - 1 | ||
| Keynote Talks | ||
| Sotiri Stathakis, Mary Bird Perkins Cancer Center, United States |
09:30-10:00 | Title: The risks of telehealth in radiation oncology: Challenges and mitigation strategies |
| TBA | 10:00-10:30 | TBA |
| Refreshment Break (10:30-10:40) | ||
| Scientific Session III | ||
| Helen Pearson, Cardiff University, United Kingdom |
10:40-11:00 | Title: Investigating BCL3 as a therapeutic target to treat prostate cancer |
| Shunfu Hu, Southern Illinois University, United States |
11:00-11:20 | Title: Mapping 2022 Cancer Mortality in Illinois?USA: Spatial-Temporal Patterns and Socio-Environmental Correlates |
| Speaker Slot Available | 11:20-11:40 | Speaker Slot Available |
| Abdulaziz Aloliqi, Qassim University, Saudi Arabia |
11:40-12:00 | Title: Identification and deciphering novel compounds dynamics against DTYMK |
| Revathi G, Apollo hospitals, Navi Mumbai, India |
12:00-12:20 | Title: Undifferentiated Uterine Sarcoma Causing Non- puerperal Uterine Inversion : A Case Report |
| Evanka Madan, Sir Ganga Ram Hospital, India |
12:20-12:40 | Title: Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell Lung Cancer patients undergoing anti-PD1 therapy |
| Badi A Alotaibi, King Saud bin Abdulaziz University For Health Sciences, Saudi Arabia |
12:40-13:00 | Title: Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Poster presentations (14:00-14:40) | ||
| Scientific Session IV | ||
| Paula Eboli, Cedars Sinai Medical Center, United States |
14:40-15:00 | Title: Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination case presentation and literature review |
| Ying Hu, Peking University of Shenzhen Hospital, China |
15:00-15:20 | Title: Summary of the Best Evidence on Perioperative Nursing Care for Patients with Gynecological Malignancy-related Lower Extremity Lymphedema Undergoing Lymphaticovenous Anastomosis |
| Speaker Slot Available | 15:20-15:40 | Speaker Slot Available |
| Luis Zapata, ICR, United Kingdom |
15:40-16:00 | Title: Quantifying Immune Selection in Cancer through Immune dN/dS: A Predictive Biomarker of Response to Immunotherapy |
| Refreshment Break(16:00-16:10) | ||
| Sirish Karri, Ariel University, Israel |
16:10-16:30 | Title: Fractal dimension–based image analysis reveals therapy-induced structural complexity and phenotypic heterogeneity in cancer cells |
| Chaochao Qin, Guangyuan Traditional Chinese Medicine Hospital, China |
16:30-16:50 | Title: The Multifaceted Roles of Chemokines in the Chronic Pancreatitis-to-Pancreatic Cancer Cascade: Implications for Pathogenesis and Precision Therapy |
| Speaker Slot Available | 16:50-17:10 | Speaker Slot Available |
| Poster presentations (14:00-14:40) | ||
| Alessandra Storm Mauricio, Christian Brothers High School, United States |
WCCRT-I | Title: Cancer awareness in teens: a hybrid cross-sectional survey and informational campaign |
| Badi A Alotaibi King Saud bin Abdulaziz University For Health Sciences, Saudi Arabia |
WCCRT-II | Title: Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters |
| Anurag Agarwal, Betsi Cadwaladr University Health Board, United Kingdom |
WCCRT-III | Title: A Post-surgical Collection Is Not Just a Collection: A Case Report of Colorectal Cancer Metastasis |
| Rihab Khalil, Hospital Of Aix En Provence, France |
WCCRT-IV | Title: A Rare Parotid Gland Metastasis in Pik3ca Mutated Hr+/Her2 Negative Breast Cancer |
| Yongming Wang, Weifang No.2 People’s Hospital, China |
WCCRT-V | Title: Natural Product from Asparagopsis taxiformis for Targeting Colorectal Cancer |
| Closing Ceremony | ||
| Please note that this program is tentative, and the timings are subject to change | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
Virtual Agenda
Will update soon....